التفاصيل البيبلوغرافية
| العنوان: |
Presurgical Medical Treatment in Prolactinomas: Surgical Implications and Pathological Characteristics From 290 Cases. |
| المؤلفون: |
Chen, Zhengyuan, Shou, Xuefei, Ji, Lijin, Cheng, Haixia, Shen, Ming, Ma, Zengyi, He, Wenqiang, Ye, Zhao, Zhang, Yichao, Qiao, Nidan, Zhang, Qilin, Wang, Yongfei |
| المصدر: |
Journal of Clinical Endocrinology & Metabolism; Jun2024, Vol. 109 Issue 6, p1433-1442, 10p |
| مصطلحات موضوعية: |
THERAPEUTICS, SURGICAL blood loss, ENDOSCOPIC surgery, DOPAMINE agonists, BROMOCRIPTINE |
| مستخلص: |
Objective To review experience regarding the treatment of prolactinomas by endoscopic endonasal surgery focusing on the association between presurgical dopamine agonist (DA) treatment and perioperative outcomes, surgical morbidities, endocrine outcomes, and pathological characteristics. Methods A single-center series of 290 cases was analyzed retrospectively and clinical data were collected. Intratumoral collagen content was assessed by Masson trichrome staining. Results Tenacious tumor consistency (27.8% vs 9.8%, P <.001) was more common in DA-pretreated patients compared with patients who underwent initial surgery. Moreover, DA-pretreated macroadenomas presented more intraoperative blood loss (200 [100-400] mL vs 175 [100-300] mL; P =.014), longer surgical duration (177 ± 95 minutes vs 154 ± 57 minutes; P =.043), and more surgical morbidities (19.4% vs 8.9%; P =.034). Additionally, DA-pretreated macroadenomas presented a higher collagen volume fraction than that of the initial surgery group (23.6 ± 2.2% vs 13.2 ± 2.1%; P =.001). Correlation analysis revealed a close correlation between collagen volume fraction and the cumulative dose of bromocriptine (BRC) in macroadenomas (r = 0.438, P <.001). Regarding endocrine outcomes, DA-pretreated microadenomas showed a lower proportion of initial remission compared with patients who underwent initial surgery (86.7% vs 100%, P =.047). Conclusion This study described increased surgical difficulty and inferior endocrine outcomes associated with tumor fibrosis secondary to presurgical BRC treatment in prolactinomas. Neurosurgeons should note that presurgical BRC treatment may render subsequent surgery more challenging. [ABSTRACT FROM AUTHOR] |
|
Copyright of Journal of Clinical Endocrinology & Metabolism is the property of Oxford University Press / USA and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
